Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5335)
All Articles published online
|
Publishing Process of This Article
|
May 10, 2013 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bayraktar S, Rocha-Lima CM. Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma. World J Clin Oncol 2013; 4(2): 29-42 [PMID: 23696960 DOI: 10.5306/wjco.v4.i2.29] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v4/i2/29.htm |
| Number | Citing Articles |
| 1 |
Alvydas Česas, Aušra Bankauskaitė, Jolanta Česienė, Jūratė Kasnauskienė. PAŽENGUSI AR METASTAZAVUSI PLAUČIŲ ADENOKARCINOMOS SU VYRAUJANČIA EGFR MUTACIJA. GYDYMO PATIRTIS IR NEPAGEIDAUJAMI REIŠKINIAI. Sveikatos mokslai 2014; 24(5): 35 doi: 10.5200/sm-hs.2014.090
|
| 2 |
Edgar Pinedo-Carpio, David Davidson, Veronica L. Martinez Marignac, Justin Panasci, Raquel Aloyz. Adaptive metabolic rewiring to chronic SFK inhibition. Oncotarget 2017; 8(40): 66758 doi: 10.18632/oncotarget.8146
|
| 3 |
Mahmoud Toulany, Julia Mihatsch, Marina Holler, Hassan Chaachouay, H. Peter Rodemann. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition. Radiotherapy and Oncology 2014; 111(2): 228 doi: 10.1016/j.radonc.2014.04.001
|
| 4 |
Kian Ngiap Chua, Li Ren Kong, Wen Jing Sim, Hsien Chun Ng, Weijie Richard Ong, Jean Paul Thiery, Hung Huynh, Boon Cher Goh. Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma. Oncotarget 2015; 6(30): 29991 doi: 10.18632/oncotarget.5031
|
| 5 |
Masayuki Aboshi, Masayuki Kaneko, Mamoru Narukawa. Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology 2014; 140(5): 839 doi: 10.1007/s00432-014-1617-3
|
| 6 |
Xiaolong Cheng, Zhenli Hu, Yi-ping Han, Chong Bai. A case report of tongue metastasis from lung squamous cell carcinoma and literature review. Medicine 2017; 96(40): e8208 doi: 10.1097/MD.0000000000008208
|
| 7 |
EC Martino, G Misso, P Pastina, S Costantini, F Vanni, C Gandolfo, C Botta, F Capone, A Lombardi, L Pirtoli, P Tassone, C Ulivieri, P Tagliaferri, MG Cusi, M Caraglia, P Correale. Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients. Cell Death Discovery 2016; 2(1) doi: 10.1038/cddiscovery.2016.25
|